Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C20H24N9O9P |
| Molecular Weight | 565.4332 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 5 / 5 |
| E/Z Centers | 1 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CC1=CN([C@H]2C[C@H](N=[N+]=[N-])[C@@H](COP(O)(=O)OC[C@@H]3CC[C@@H](O3)N4C=NC5=C4N=CNC5=O)O2)C(=O)NC1=O
InChI
InChIKey=XURFYCWNUGWGDL-VQJWOFKYSA-N
InChI=1S/C20H24N9O9P/c1-10-5-28(20(32)25-18(10)30)15-4-12(26-27-21)13(38-15)7-36-39(33,34)35-6-11-2-3-14(37-11)29-9-24-16-17(29)22-8-23-19(16)31/h5,8-9,11-15H,2-4,6-7H2,1H3,(H,33,34)(H,22,23,31)(H,25,30,32)/t11-,12-,13+,14+,15+/m0/s1
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Synthesis, antiviral activity, cytotoxicity and cellular pharmacology of l-3'-azido-2',3'-dideoxypurine nucleosides. | 2011-09 |
|
| Generation of drug-resistant variants of human immunodeficiency virus type 1 by in vitro passage in increasing concentrations of 2',3'-dideoxycytidine and 2',3'-dideoxy-3'-thiacytidine. | 1993-01 |
|
| Activities of 3'-azido-3'-deoxythymidine nucleotide dimers in primary lymphocytes infected with human immunodeficiency virus type 1. | 1990-06 |
|
| Nucleotide dimers suppress HIV expression in vitro. | 1988-12 |
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
C106062
Created by
admin on Mon Mar 31 18:47:17 GMT 2025 , Edited by admin on Mon Mar 31 18:47:17 GMT 2025
|
PRIMARY | |||
|
121135-53-3
Created by
admin on Mon Mar 31 18:47:17 GMT 2025 , Edited by admin on Mon Mar 31 18:47:17 GMT 2025
|
PRIMARY | |||
|
MRB2FUC61I
Created by
admin on Mon Mar 31 18:47:17 GMT 2025 , Edited by admin on Mon Mar 31 18:47:17 GMT 2025
|
PRIMARY | |||
|
135462914
Created by
admin on Mon Mar 31 18:47:17 GMT 2025 , Edited by admin on Mon Mar 31 18:47:17 GMT 2025
|
PRIMARY | |||
|
DTXSID60153167
Created by
admin on Mon Mar 31 18:47:17 GMT 2025 , Edited by admin on Mon Mar 31 18:47:17 GMT 2025
|
PRIMARY |
SUBSTANCE RECORD
